Global Personalized Medicine Bioinformatics Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Personalized Medicine Bioinformatics Industry Compare Between 2025 And 2029?

The personalized medicine bioinformatics market size has demonstrated significant growth in recent years. It is projected to expand from $3.40 billion in 2024 to $3.87 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.7%. This historic growth can be attributed to the rising adoption of genomic sequencing technologies, an increasing demand for targeted therapies, the expansion of bioinformatics software solutions, a broader scope of research and development in personalized medicine, and robust regulatory support for precision medicine initiatives.

The personalized medicine bioinformatics market is projected to experience swift expansion in the coming years, reaching $6.40 billion by 2029, with a compound annual growth rate (CAGR) of 13.4%. This anticipated growth can be linked to factors such as the incorporation of artificial intelligence and machine learning, a greater reliance on real-world data and predictive analytics, the proliferation of cloud-based bioinformatics platforms, an increase in partnerships between healthcare and technology firms, and an enhanced emphasis on patient-focused treatment methods. Key developments expected during this period involve the creation of predictive analytics instruments, breakthroughs in multi-omics integration, the implementation of real-time patient monitoring systems, progress in genome editing technologies, and the expansion of healthcare models centered around patients.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28294&type=smp

Which Industry Drivers Are Expected To Accelerate The Personalized Medicine Bioinformatics Market From 2025 To 2029?

The increasing need for personalized medicine is projected to fuel the expansion of the personalized medicine bioinformatics market in the future. This medical approach involves tailoring prevention strategies, diagnoses, and treatments to an individual’s unique genetic profile, health status, and lifestyle elements. Its growth is attributed to progress in genomics and data analytics, which facilitate precise genetic profiling, leading to more accurate therapies, better patient results, and less reliance on trial-and-error methods. Personalized medicine bioinformatics analyzes genomic and clinical information to uncover insights into a patient’s health, aiding in making precise treatment decisions, forecasting drug responses, and directing targeted therapies for enhanced, individualized patient care. For example, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care entity, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six approvals in 2022. Consequently, the rising demand for personalized medicine is a key factor propelling the expansion of the personalized medicine bioinformatics market.

What Are The Major Segment Types Covered In The Personalized Medicine Bioinformatics Market?

The personalized medicine bioinformatics market covered in this report is segmented as

1) By Technology: Gene Sequencing, Pharmacogenomics, Microarray Technology, Artificial Intelligence-Driven Analytics Platforms, Other Technologies

2) By Application: Genomics, Proteomics, Transcriptomics, Metabolomics, Epigenomics, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Diagnostics Laboratories, Hospitals And Academic Medical Centers, Contact Research Organizations and Biobanks, Other End-Users

Subsegments:

1) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS)

2) By Pharmacogenomics: Drug-Gene Interaction Analysis, Adverse Drug Reaction (ADR) Prediction, Biomarker Discovery, Personalized Drug Response Profiling

3) By Microarray Technology: DNA Microarray, RNA Microarray, Protein Microarray, Comparative Genomic Hybridization (CGH) Microarray

4) By Artificial Intelligence-Driven Analytics Platforms: Machine Learning-Based Platforms, Deep Learning-Based Platforms, Natural Language Processing (NLP) Platforms, Predictive Analytics Platforms, Clinical Decision Support Systems (CDSS)

5) By Other Technologies: Proteomics Analysis, Metabolomics Analysis, Epigenomics Profiling, Bioinformatics Cloud Platforms

Which Key Trends Are Expected To Influence The Personalized Medicine Bioinformatics Market In The Coming Years?

Key companies active in the personalized medicine bioinformatics market are focused on developing advanced solutions like predictive analytics platforms to improve disease prediction and enhance patient outcomes. A predictive analytics platform utilizes machine learning, algorithms, and statistical models to analyze historical and real-time data for forecasting results, enabling healthcare providers to anticipate risks, refine treatments, and make proactive decisions. For instance, in April 2023, Certis Oncology Solutions, a US-based biotechnology company, launched CertisAI, a predictive analytics platform. This AI/ML-based platform employs big data, statistical algorithms, and machine learning to predict drug efficacy based on gene expression biomarkers, with the aim of accelerating drug discovery and the development of companion diagnostics in precision oncology. The platform is validating its proprietary approach for predicting therapeutic response and supporting its offering as a service accessible to biopharmaceutical companies for improved early drug development decisions and personalized cancer treatment strategies.

Which Global Market Leaders Are Shaping The Future Of The Personalized Medicine Bioinformatics Sector?

Major companies operating in the personalized medicine bioinformatics market are F. Hoffmann-La Roche AG, Merck KGaA Darmstadt Germany, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Guardant Health Inc., Sophia Genetics SA, DNAnexus Inc., Deep Genomics Inc., Congenica Ltd, Phase Genomics Inc., Analome Inc., Pluto Bioinformatics Inc., BioBam Bioinformatics S.L., OncoBox Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-bioinformatics-global-market-report

How Does The Personalized Medicine Bioinformatics Market Perform Across Key Geographic Regions?

North America was the largest region in the personalized medicine bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personalized medicine bioinformatics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Personalized Medicine Bioinformatics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28294&type=smp

Browse Through More Reports Similar to the Global Personalized Medicine Bioinformatics Market 2025, By The Business Research Company

Bioinformatics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

Personalized Medicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Bioinformatics Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioinformatics-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795